Agreed: nobody had any right to hope for better than this even...

Agreed: nobody had any right to hope for better than this even given the company's track record of over-delivering.

This trial could not have yielded better results, shy of finding that even the mere mention of IHL-42x cured all participants of their OSA. (Which would have been a bad result for our finances, since nobody would need to buy the drug: they could just talk about it LOL)

I believe the clock really starts now on acquisition/licensing. Nobody can say how long it might take for a credible offer to come in. It may already be in, and might have been contingent upon approval of the final results by the licensee/acquirer. But regardless, we can be certain multiple parties will be drafting their offers now, if they haven't already. Even if they decide to keep their powder dry until the pivotal trial results, you can be sure their planning is not going to wait.

Speaking of keeping powder dry, my only regret is I'm not in a position to increase my holding. I'd happily triple it if I were. But I'm very happy with my holding so no need to be greedy.

Congratulations to each and every one of us who has believed in Incannex, its drug candidates and its mission. IHL-42x is a winner. I pity the fool that bets their business against it: they should join us and not try to beat us. Looking at you, CPAP manufacturers.